Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacksTachdjian R, Savic S, Fridman M, Frade JP, Fasehun M, Audhya PK
Allergy and Asthma Proceedings
Understanding Why Hereditary Angioedema Patients Often Do Not Carry Their On-Demand Treatment with ThemGeng B, van Kooten S, Heckmann M, Danese S, Goga L, Radojicic C
ACAAI 2023
Anxiety Associated with On-Demand Treatment of HAE Attacks May Result in Suboptimal Attack ManagementManning M, van Kooten S, Heckmann M, Danese S, Goga L, Ogbogu PU
ACAAI 2023
In Their Own Words – Patient Descriptions of the Earliest Recognition of HAE Attack OnsetManning ME, Burnette AF, van Kooten S, Heckmann M, Danese S, Goga L, Guilarte M
HAEA National Summit 2023
Recognizing the Importance of Early On-Demand Treatment in the HAE Attack JourneyJones DH, Ogbogu P, van Kooten S, Heckmann M, Danese S, Goga L, Magerl M
HAEA National Summit 2023
Understanding the complex decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacksGrumach A, van Kooten S, Heckmann M, Danese S, Goga L, Garcez T
EAACI 2023
Remaining burden of hereditary angioedema (HAE) attacks despite modern long-term prophylaxisBetschel S, van Kooten S, Heckmann M, Danese S, Caballero T
EAACI 2023
Patients delay treating hereditary angioedema (HAE) attacks with currently available, injectable, on-demand therapies: associated with on-demand treatment of hereditary angioedema (HAE) attacksValerieva A, van Kooten S, Heckmann M, Danese S, Goga L, Longhurst H
EAACI 2023
HAE Patients Decision to Carry On-demand Treatment When Away from HomeBetschel S, van Kooten S, Heckmann M, Danese S, Goga L, Guilarte M
C1 Inhibitor Workshop 2023
Route of Administration Preferences of People with Hereditary Angioedema for On-demand Treatment: A US-based Qualitative StudyDesai V, Ledia Goga L, Czado S, Brown M, Myers K, Bukstein D, Audhya PK, Bouillet L
C1 Inhibitor Workshop 2023
